Literature DB >> 15701046

Structure and activity of NO synthase inhibitors specific to the L-arginine binding site.

S Ya Proskuryakov1, A G Konoplyannikov, V G Skvortsov, A A Mandrugin, V M Fedoseev.   

Abstract

Synthesis of compounds containing a fragment similar to the guanidine group of L-arginine, which is a substrate of nitric oxide synthase (NOS), is the main direction in creating NOS inhibitors. The inhibitory effect of such compounds is caused not only by their competition with the substrate for the L-arginine-binding site and/or oxidizing center of the enzyme (heme) but also by interaction with peptide motifs of the enzyme that influence its dimerization, affinity for cofactors, and interaction with associated proteins. Structures, activities, and relative in vitro and in vivo specificities of various NOS inhibitors (amino acid and non-amino acid) with linear or cyclic structure and containing guanidine, amidine, or isothiuronium group are considered. These properties are mainly analyzed by comparison with effects of the inhibitors on the inducible NOS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15701046

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  5 in total

1.  L337H mutant of rat neuronal nitric oxide synthase resembles human neuronal nitric oxide synthase toward inhibitors.

Authors:  Jianguo Fang; Haitao Ji; Graham R Lawton; Fengtian Xue; Linda J Roman; Richard B Silverman
Journal:  J Med Chem       Date:  2009-07-23       Impact factor: 7.446

2.  Known regulators of nitric oxide synthase and arginase are agonists at the human G-protein-coupled receptor GPRC6A.

Authors:  Bolette Christiansen; Petrine Wellendorph; Hans Bräuner-Osborne
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

3.  Inducible nitric oxide synthase increases secretion from inflamed salivary glands.

Authors:  Patricia N Correia; Guy H Carpenter; Katherine L Paterson; Gordon B Proctor
Journal:  Rheumatology (Oxford)       Date:  2009-11-20       Impact factor: 7.580

4.  A combination of 3D-QSAR, molecular docking and molecular dynamics simulation studies of benzimidazole-quinolinone derivatives as iNOS inhibitors.

Authors:  Hao Zhang; Jinhang Zan; Guangyun Yu; Ming Jiang; Peixun Liu
Journal:  Int J Mol Sci       Date:  2012-09-10       Impact factor: 6.208

5.  Oxidative stress induces BH4 deficiency in male, but not female, SHR.

Authors:  Ellen E Gillis; Krystal N Brinson; Olga Rafikova; Wei Chen; Jacqueline B Musall; David G Harrison; Jennifer C Sullivan
Journal:  Biosci Rep       Date:  2018-07-02       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.